References
- Umar A, Dunn Barbara K, Peter G. Future directions in cancer prevention. Nat Rev Cancer 2012;12:835–48
- Scott AM, Wolchok DJ, Old JL. Antibody therapy of cancer. Nat Rev Cancer 2012;12:278–87
- World Health Organisation (WHO). World Cancer Report, 3rd February 2014
- Bray F, Ren JS, Masuger E, Feraly J. Global estimates of cancer prevalence for 27-sites in the adult population in 2008. Int J Cancer 2013;132:1133–45
- Jemal A, Brey F, Melissa M, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90
- Fraile JM, Quesada V, Rodriguez D, et al. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene 2012;31:2373–88
- Holler D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nat Rev 2009;458:438–44
- Ohata T, Fukuda M. Ubiquitin and breast cancer. Oncogene 2004;23:2079–88
- Broemer M, Meier P. Ubiquitin-mediated regulation of apoptosis. Trend Cell Bio Rev 2009;19:130–40
- Sapataro V, Norbury C, Harris AL. The ubiquitin-proteasome pathway in cancer. Brit J Cancer 1998;77:448–55
- Aparna M, Gelmann EP. The ubiquitin proteasome pathway and its role in cancer. J Clin Oncol 2005;23:4776–89
- Okamoto Y, Ozaki T, Miyazaki K, et al. UbcH10 is the cancer related E2 ubiquitin-conjugating enzyme. Cancer Res 2003;63:4167–73
- Ciechanover A. The ubiquitin–proteasome pathway: on protein death and cell life. EMBO J 1998;17:7151–60
- Hochstraseer M. Origin and function of ubiquitin-like proteins. Nat Rev 2009;458:422–9
- Lynn B, James L, Lawrence RD, et al. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Dis 2011;10:29–46
- Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin–proteasome system. Nat Rev Drug Dis 2006;5:596–613
- Sarcevic B, Mawson A, Baker Rohan T, Sutherland R. Regulation of the ubiquitin-conjugating enzyme hHR6A by CDK-mediated phosphorylation. EMBO J 2002;21:2009–18
- Sarita Rajender P, Ramasree D, Bhargavi K, et al. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer – a review. J Recept Signal Transduct 2010;30:206–13
- Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Can Res 2006;6:362–81
- Langaki A, Sleddens LE, Cappellen AW, et al. Human RAD 18 interacts with ubiquitylated chromatin components and facilitates RAD9 recruitment to DNA double stand breaks. PLoS One 2011;6:1–14
- Xin H, Lin W, Sumanasekara W, et al. The human RAD18 gene product interacts with HHR6A and HHR6B. Nucleic Acid Res 2000;28:2847–54
- Fu Y, Zhu Y, Zhang K, et al. Rad6-Rad18 mediates a eukaryotic SOS response by ubiquitinating the 9-1-1 checkpoints clamp. Cell 2008;133:601–11
- Molineaux SM. Molecular pathways: targeting proteasomal protein degradation in cancer. Am Assoc Clin Cancer Res 2012;18:15–20
- Sasin JM, Bujnicki JM. COLORADO3D, a web server for the visual analysis of protein structures. Nucleic Acids Res 2004;32:586–9
- Gasteiger E, Gattiker A, Hooogland C, et al. Expasy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003;31:3784–8
- Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990;215:403–10
- Altschl SF, Madden TL, Schaffer A, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389–402
- Kelley LA, Sternberg MJE. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 2009;4:363–71
- Christian C, Jonathan DB, Geoffrey JB. The Jpred 3 secondary structure prediction server. Nucleic Acids Res 2008;36:197–201
- Thompson JD, Higgins DG, Gibson TJ. Clustal W: improving the sensitivity of sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673–80
- Gonnet GH, Cohen MA, Benner SA. Exhaustive matching of the entire protein sequence database. Science 1992;256:1443–5
- Marti-Renom MA, Stuart AC, Fiser A, et al. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000;29:291–325
- Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993;234:779–815
- Guex N, Peitsch MC. SWISS-MODEL and the Swiss-pdb viewer: an environment for comparative protein modelling. Electrophoresis 1997;18:2714–23
- Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetic and properties of organic liquids. J Am Chem Soc 1996;118:11225–36
- Jorgensen L, Maxwell DS, Tirado-Rives J. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. J Am Chem Soc 1996;110:1657–66
- Salam NK, Nuti R, Sherman W. Novel method for generating structure based pharmacophores using energetic analysis. J Chem Inf Model 2009;49:2356–68
- Laskowsky RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereo chemical quality of protein structures. J Appl Crystallogr 1993;26:283–91
- Laskowsky RA, Rullmannn JA, MacArthur MW, et al. AQUA and PROCHEK-NMR: programs for checking the quality of protein structure solved by NMR. J Biomol NMR 1996;8:477–86
- Colovos C, Yeates TO. Verification of protein structures – patterns of non-bonded atomic interactions. Prot Sci 1993;2:1511–19
- Kamy Z, Eisenberg D. The three-dimensional profile method using residue preference as a continuous function of residue environment. Prot Sci 1994;3:687–95
- Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:407–41
- Dundas J, Ouyang Z, Tseng J, et al. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 2006;34:116–18
- Laurie AT, Jackson RM. Q-site finder: an energy-based method for the prediction of protein–ligand sites. Bioinformatics 2005;21:1908–16
- Rong CL, Zhiping W. ZDOCK: an initial-stage protein docking algorithm. Proteins 2003;52:80–7
- Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein–ligand complexes. J Med Chem 2006; 49:6177–96
- Loakimidis L, Thoukydidis L, Mirza A, et al. Benchmarking the reliability of Qikprop, correlation between experimental and predicted values. QSAR Comb Sci 2008;27:445–6
- Lill MA, Danielson ML. Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des 2011;25:13–19
- Sali A, Pottertone L, Yuan F, et al. Evaluation of comparative protein modeling by MODELLER. Proteins 1995;23:318–26
- Vasavi M, Kiran Kumar M, Sarita Rajender P, Uma V. Identification of novel leads applying insilico studies for mycobacterium multidrug resistant (MMR) protein. J Biomol Struct Dyn 2014;32:1889–906
- Bhargavi K, Ramasree D, Murthy DK, Uma V. Towards the virtual screening of BIK inhibitors with the homology-modeled protein structure. Med Chem Res 2013;22:1184–96
- Singh T, Biswas D, Jayaram B. AADS – an automated active site identification, docking and scoring protocol for protein targets based on physicochemical descriptors. J Chem Inf Model 2011;51:2515–27
- Amid MR, Mehdi S, Hamid P, Sayed AM. Impact of residue accessible surface area on the prediction of protein secondary structures. Bioinformatics 2008;9:1–11